Verge Genomics, a leading biotechnology firm, has declared a partnership with Ferrer to co-foster VRG50635, Verge’s lead candidate, for the treatment of irregular and familial types of amyotrophic lateral sclerosis (ALS) in Europe, Central and...
Baby Memorial Hospital, Kozhikode, a venerable institution with over three decades of unwavering commitment to accessible and quality healthcare, announces the launch of the ‘ContinuousConnectedCare@BMH’ initiative. In a pioneering move, all ward...
Wipro GE Healthcare services declared funding of more than $1 billion (Rs 8000 crore) in manufacturing results and nearby research and development (R&D) for the next five years. This essential speculation supports Wipro GE Healthcare’s local...
AstraZeneca's Ultomiris (ravulizumab-cwvz) has been sanctioned in the United States as the initial and long-acting C5 supplement inhibitor for the treatment of grown-up patients with anti- aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis...
The pharmaceutical firm Novo Nordisk has consented to purchase Cardior Pharmaceuticals for €1bn (£856bn) as it ventures into the cardiovascular pipeline. The Danish pharmaceutical drugmaker is building an arrangement of treatments in areas...
XRP Healthcare announced a strategic alliance with Isansys Lifecare, a leading digital healthcare technology innovator, to improve Uganda's healthcare infrastructure and services. This cooperation is set to change patient consideration through the...
In a huge step towards improving stroke care and determination, Aster MIMS Emergency Clinic in Kozhikode has joined hands with Qure.ai, a provider of AI solutions for clinical imaging. This cooperation presents a creative artificial intelligence...
The World Health Organization (WHO) has developed a brand-new toolkit with the help of partners that aims to provide healthcare professionals with the knowledge and self-assurance they need to communicate health and climate change...
Leading vaccines & bio-therapeutics manufacturers, Bharat Biotech Global Ltd added that it began clinical preliminaries of the tuberculosis immunization Mtbvac on adults in India. This is the initial immunization against Tuberculosis from a human...
Leading pharmaceutical firm Dr. Reddy's Laboratories announced that it has signed a license agreement with US-based biopharma Pharmazz to commercialize the first-in-class breakthrough medication Centhaquine in India. Centhaquine, developed by...